Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Zidovudine CAS 30516-87-1 For HIV Treatment

Zidovudine CAS 30516-87-1 For HIV Treatment

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 30516-87-1

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:

Zidovudine CAS 30516-87-1

,

Zidovudine For HIV Treatment

CAS NO::
30516-87-1
Appearance::
White To Off-white Crystals
Molecular Formula::
C10H13N5O4
Molecular Weight::
267.24100
EINECS NO::
623-849-4
MDL NO::
MFCD00006536
CAS NO::
30516-87-1
Appearance::
White To Off-white Crystals
Molecular Formula::
C10H13N5O4
Molecular Weight::
267.24100
EINECS NO::
623-849-4
MDL NO::
MFCD00006536
Zidovudine CAS 30516-87-1 For HIV Treatment

Product Description:

Product Name: Zidovudine CAS NO: 30516-87-1

 

 

Synonyms:

3'-azido-3'-droxythymidine;

1-(3-Azido-2,3-dideoxy-β-D-ribofuranosyl)thymine;

azidothymidine;

 

 

Chemical & Physical Properties:

Appearance: White to off-white Crystals

Assay :≥99.0%

Melting Point: 106-112℃

Refractive Index: 47 ° (C=1, H2O)

Water Solubility: 1-5 g/100 mL at 17℃

Storage Condition: -20℃

Sensitive: Light Sensitive & Hygroscopic

 

 

Safety Information:

RTECS: XP2072000

Safety Statements: S36/37/39-S45

HS Code: 2933990090

WGK Germany: 3

Risk Statement: R40

Hazard Code: Xn

Signal Word: Warning

Hazard Declaration: H351

Caution Statement: P281

Symbol: GHS08

 

 

Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI), widely used to treat HIV infection. Zidovudine increases CRISPR/Cas9-mediated editing frequency. Zidovudine, also known as azidothymidine (AZT), is an antiviral agent acting via reverse transcnptase inhibition. It was first launched in the U.K. and subsequently introduced in over a dozen countries for the management of severe manifestations of HIV infection. In patients with AIDS and ARC, zidovudine reduces the risk of opportunistic infections and prolongs survival time. In symptom-free patients it shows promise in halting further immunological deterioration.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.